Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 8,110.00
-140.00 (-1.70%)
At close: May 29, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 68.27 billion as of June 1, 2026. Its market cap has decreased by -20.24% in one year.
Market Cap
68.27B
Enterprise Value
n/a
Revenue
107.87B
Ranking
n/a
PE Ratio
17.09
Stock Price
8,110.00
Market Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 68.27B, an increase of 176.67%. That is a compound annual growth rate of 4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 68.27B | -29.73% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 88.56B |
| Polaris AI Pharma | 84.88B |
| Daehan Nupharm | 83.93B |
| Pharos iBio | 81.56B |
| Sinsin Pharmaceutical | 76.46B |
| GL Pharm Tech | 74.06B |
| Optipharm.CO.,LTD | 69.76B |
| Samik Pharmaceutical Company LTD. | 63.15B |